Loading...
XSHG600771
Market cap1.29bUSD
Dec 26, Last price  
19.24CNY
1D
-0.36%
1Q
-5.22%
Jan 2017
-19.45%
Name

GuangYuYuan Chinese Herbal Medicn Co Ltd

Chart & Performance

D1W1MN
XSHG:600771 chart
P/E
104.55
P/S
7.33
EPS
0.18
Div Yield, %
0.15%
Shrs. gr., 5y
7.23%
Rev. gr., 5y
-4.53%
Revenues
1.28b
+29.09%
563,376,147549,202,754540,371,537531,192,256307,725,961257,641,102229,820,920228,929,042260,653,806268,111,311354,154,540428,436,063936,993,2281,168,684,8141,618,764,0101,217,097,4711,109,430,046854,223,148994,694,7901,284,015,751
Net income
90m
30,111,08835,305,18312,622,3300331,248,9820193,629,030299,716,482355,571,479036,646,3832,030,309122,810,065236,804,798374,108,052130,068,24532,003,0010090,078,565
CFO
215m
-14.97%
87,602,100290,027,704178,973,1620035,171,4450000000000081,368,872253,426,205215,499,935
Dividend
Jul 30, 20030.068 CNY/sh

Profile

GuangYuYuan Chinese Herbal Medicine Co., Ltd. manufactures and sells Chinese medicinal products. The company offers traditional and fine Chinese medicines, as well as health wines. It provides its products in the form of pills, powders, tablets, hard capsules, granules, oral liquids, decoctions, and wines. The company was formerly known as Topsun Science And Technology Co Ltd. and changed its name to GuangYuYuan Chinese Herbal Medicine Co., Ltd. in July 2013. GuangYuYuan Chinese Herbal Medicine Co., Ltd. is based in Xi'an, China.
URL
https://www.guangyuyuan.com/
IPO date
Nov 05, 1996
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
1,284,016
29.09%
994,695
16.44%
854,223
-23.00%
Cost of revenue
923,410
1,254,116
1,172,514
Unusual Expense (Income)
NOPBT
360,605
(259,421)
(318,291)
NOPBT Margin
28.08%
Operating Taxes
7,523
Tax Rate
2.09%
NOPAT
353,082
(259,421)
(318,291)
Net income
90,079
 
Dividends
(14,335)
Dividend yield
0.11%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
245,923
229,132
257,860
Long-term debt
78,222
210,003
70,000
Deferred revenue
15,103
13,630
15,354
Other long-term liabilities
9,269
1
1
Net debt
39,496
164,103
144,923
Cash flow
Cash from operating activities
215,500
253,426
81,369
CAPEX
(2,511)
Cash from investing activities
(1,185)
Cash from financing activities
(201,311)
FCF
702,559
142,972
(195,748)
Balance
Cash
258,763
246,398
145,149
Long term investments
25,886
28,634
37,788
Excess cash
220,448
225,298
140,226
Stockholders' equity
(107,447)
1,005,147
1,025,765
Invested Capital
1,924,717
1,929,715
2,322,498
ROIC
18.32%
ROCE
19.70%
EV
Common stock shares outstanding
500,436
489,491
489,491
Price
26.99
-2.98%
27.82
-35.39%
43.06
188.41%
Market cap
13,506,780
-0.81%
13,617,644
-35.39%
21,077,489
188.41%
EV
13,558,012
13,804,039
21,263,836
EBITDA
406,620
(220,170)
(279,905)
EV/EBITDA
33.34
Interest
151
25,812
30,240
Interest/NOPBT
0.04%